34050 Federal Register / Vol. 77, No. 111 / Friday, June 8, 2012 / Notices 

Insurance Program; and No. 93.774, 

Medicare—Supplementary Medical 

Insurance Program) 

Dated: June 5, 2012. 

Marilyn Tavenner, 

Acting Administrator, Centers for Medicare 

& Medicaid Services. 

[FR Doc. 2012–13998 Filed 6–7–12; 8:45 am] 

BILLING CODE 4120–01–P 

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

Centers for Medicare & Medicaid 

Services 

[CMS–8051–N] 

Medicare Program; Meeting of the 

Medicare Economic Index Technical 

Advisory Panel—June 25, 2012 

AGENCY: Centers for Medicare & 

Medicaid Services (CMS), HHS. 

ACTION: Notice of meeting. 

SUMMARY: This notice announces that a 

public meeting of the Medicare 

Economic Index Technical Advisory 

Panel (‘‘the Panel’’) will be held on 

Monday, June 25, 2012. The purpose of 

the Panel is to review all aspects of the 

Medicare Economic Index (MEI). This 

second meeting will focus on MEI pricemeasurement proxies and the index’s 

productivity adjustment. This meeting 

is open to the public in accordance with 

the Federal Advisory Committee Act (5 

U.S.C. App. 2, section 10(a)). 

DATES: Meeting Date: The public 

meeting will be held on Monday, June 

25, 2012 from 8:30 a.m. until 5 p.m., 

Eastern Daylight Time (EDT). 

Deadline for Submission of Written 

Comments: Written comments must be 

received at the mailing or email address 

specified in the section of this notice 

entitled, FOR FURTHER INFORMATION

CONTACT, by 5 p.m. EDT, Monday, June 

18, 2012. Once submitted, all comments 

are considered to be final. 

Deadlines for Speaker Registration 

and Presentation Materials: The 

deadline to register to be a speaker and 

to submit PowerPoint presentation 

materials and any other written 

materials that will be used in support of 

an oral presentation is 5 p.m. EDT, 

Monday, June 18, 2012. Speakers may 

register by contacting Toya Via, HCD 

International, by phone at (301) 552– 

8803 or via email at MEITAP@hcdi.com. 

Materials that will be used in support of 

an oral presentation must be received at 

the mailing or email address specified 

in the FOR FURTHER INFORMATION

CONTACT section of this notice, by 5 p.m. 

EDT, Monday, June 18, 2012. 

Deadline for All Other Attendees 

Registration: Individuals may register 

online at http://www.hcdi.com/mei/ or 

by phone by contacting Toya Via, HCD 

International, at (301) 552–8803 by 5 

p.m. EDT, Monday, June 18, 2012. 

We will be broadcasting the meeting 

live via webinar and conference call (for 

audio purposes). Webinar details will be 

sent to registered attendees. 

Deadline for Submitting a Request for 

Special Accommodations: Persons 

attending the meeting who are hearing 

or visually impaired, or have a 

condition that requires special 

assistance or accommodations, are 

asked to contact the Designated Federal 

Officer as specified in the FOR FURTHER

INFORMATION CONTACT section of this 

notice, by 5 p.m. EDT, Monday, June 18, 

2012. 

ADDRESSES: Meeting Location: The 

meeting will be held in the Media 

Center of the Centers for Medicare & 

Medicaid Services (CMS), 7500 Security 

Boulevard, Baltimore, MD 21244. 

FOR FURTHER INFORMATION CONTACT: John 

Poisal, Designated Federal Officer, 

Centers for Medicare & Medicaid 

Services, Office of the Actuary, Mail 

stop N3–02–02, 7500 Security 

Boulevard, Baltimore, MD 21244 or 

contact Mr. Poisal by phone at (410) 

786–6397 or via email at 

John.Poisal@cms.hhs.gov. Press 

inquiries are handled through the CMS 

Press Office at (202) 690–6145. 

SUPPLEMENTARY INFORMATION:

I. Background 

The Medicare Economic Index 

Technical Advisory Panel (‘‘the Panel’’) 

was established by the Secretary to 

conduct a technical review of the 

Medicare Economic Index (MEI). The 

review will include the inputs, input 

weights, price-measurement proxies, 

and productivity adjustment. For more 

information on the Panel, see the 

October 7, 2011 Federal Register (76 FR 

62415). You may view and obtain a 

copy of the Secretary’s charter for the 

Panel at https://www.cms.gov/

Regulations-and-Guidance/Guidance/

FACA/MEITAP.html. The members of 

the Panel are: Dr. Ernst Berndt, Dr. 

Robert Berenson, Dr. Zachary Dyckman, 

Dr. Kurt Gillis, and Ms. Kathryn Kobe. 

This notice announces the Monday, 

June 25, 2012 public meeting of the 

Panel. This meeting will focus on MEI 

price-measurement proxies and the 

index’s productivity adjustment. 

II. Meeting Format 

This meeting is open to the public. 

There will be up to 45 minutes allotted 

at this meeting for the Panel to hear oral 

presentations from the public. Time 

allotted for each presentation may be 

limited. If the number of registrants 

requesting to speak is greater than can 

be reasonably accommodated during the 

scheduled open public hearing session, 

we will conduct a lottery to determine 

the speakers for the scheduled open 

public hearing session. The contact 

person will notify interested persons 

regarding their request to speak by 5 

p.m. EDT, Wednesday, June 20, 2012. 

Any presentations that are not selected 

based on the lottery will be forwarded 

to the panel for consideration. For this 

meeting, public comments should focus 

on MEI price-measurement proxies and 

the index’s productivity adjustment. We 

require that you declare at the meeting 

whether you have any financial 

involvement with manufacturers (or 

their competitors) of any items or 

services being discussed. 

The Panel will deliberate openly on 

the topics under consideration. 

Interested persons may observe the 

deliberations, but the Panel will not 

hear further comments during this time 

except at the request of the chairperson. 

The Panel will also allow up to 15 

minutes for an unscheduled open public 

session for any attendee to address 

issues specific to the topics under 

consideration. 

III. Registration Instructions 

HCD International is coordinating 

meeting registration. While there is no 

registration fee, individuals must 

register to attend. You may register 

online at http://www.hcdi.com/mei/ or 

by phone by contacting Toya Via, HCD 

International, at (301) 552–8803, by the 

date specified in the DATES section of 

this notice. Please provide your full 

name (as it appears on your 

government-issued photographic 

identification), address, organization, 

telephone, and email address. At the 

time of registration, you will be asked to 

designate if you plan to attend in person 

or via webinar. You will receive a 

registration confirmation with 

instructions for your arrival at the CMS 

complex or you will be notified that the 

seating capacity has been reached. 

IV. Security, Building, and Parking 

Guidelines 

This meeting will be held in a Federal 

Government building; therefore, Federal 

security measures are applicable. We 

recommend that confirmed registrants 

arrive reasonably early, but no earlier 

than 45 minutes prior to the start of the 

meeting, to allow additional time to 

clear security. Security measures 

include the following: 

mstockstill on DSK4VPTVN1PROD with NOTICES

Federal Register / Vol. 77, No. 111 / Friday, June 8, 2012 / Notices 34051 

• Presentation of government-issued 

photographic identification to the 

Federal Protective Service or Guard 

Service personnel. 

• Inspection of vehicle’s interior and 

exterior (this includes engine and trunk 

inspection) at the entrance to the 

grounds. Parking permits and 

instructions will be issued after the 

vehicle inspection. 

• Inspection, via metal detector or 

other applicable means, of all persons 

entering the building. We note that all 

items brought into CMS, whether 

personal or for the purpose of 

presentation or to support a 

presentation, are subject to inspection. 

We cannot assume responsibility for 

coordinating the receipt, transfer, 

transport, storage, set-up, safety, or 

timely arrival of any personal 

belongings or items used for 

presentation or to support a 

presentation. 

Note: Individuals who are not registered in 

advance will not be permitted to enter the 

building and will be unable to attend the 

meeting. The public may not enter the 

building earlier than 45 minutes prior to the 

convening of the meeting. All visitors must 

be escorted in areas other than the lower and 

first floor levels in the Central Building. 

Authority: 5 U.S.C. App. 2, section 10(a). 

Dated: June 5, 2012. 

Marilyn Tavenner, 

Acting Administrator, Centers for Medicare 

& Medicaid Services. 

[FR Doc. 2012–13988 Filed 6–7–12; 8:45 am] 

BILLING CODE 4120–01–P 

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

Food and Drug Administration 

[Docket Nos. FDA–2010–E–0333 and FDA– 

2010–E–0334] 

Determination of Regulatory Review 

Period for Purposes of Patent 

Extension; KALBITOR; Correction 

AGENCY: Food and Drug Administration, 

HHS. 

ACTION: Notice; correction. 

SUMMARY: The Food and Drug 

Administration (FDA) is correcting a 

notice that appeared in the Federal 

Register of May 2, 2012 (77 FR 26017). 

The document concerned FDA’s 

determination of the regulatory review 

period for KALBITOR. The document 

published with an incorrect patent 

number for KALBITOR. This document 

corrects that error. 

FOR FURTHER INFORMATION CONTACT: 

Beverly Friedman, Office of Regulatory 

Policy, Food and Drug Administration, 

10903 New Hampshire Ave., Bldg. 51, 

Rm. 6284, Silver Spring, MD 20993– 

0002, 301–796–3602. 

SUPPLEMENTARY INFORMATION: In FR Doc. 

2012–26017 in the Federal Register of 

Wednesday, May 2, 2012, the following 

correction is made: 

1. On page 26017, in the third 

column, in the last paragraph, ‘‘U.S. 

Patent Nos. 5,795,685 and 7,276,480’’ is 

corrected to read ‘‘U.S. Patent Nos. 

5,795,865 and 7,276,480.’’ 

Dated: May 29, 2012. 

Jane A. Axelrad, 

Associate Director for Policy, Center for Drug 

Evaluation and Research. 

[FR Doc. 2012–13902 Filed 6–7–12; 8:45 am] 

BILLING CODE 4160–01–P 

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

Food and Drug Administration 

[Docket No. FDA–2012–N–0548] 

Drug Safety and Risk Management 

Advisory Committee; Notice of Meeting 

AGENCY: Food and Drug Administration, 

HHS. 

ACTION: Notice. 

This notice announces a forthcoming 

meeting of a public advisory committee 

of the Food and Drug Administration 

(FDA). The meeting will be open to the 

public. 

Name of Committee: Drug Safety and 

Risk Management Advisory Committee. 

General Function of the Committee: 

To provide advice and 

recommendations to the Agency on 

FDA’s regulatory issues. 

Date and Time: The meeting will be 

held on October 29, 2012, from 8 a.m. 

to 5 p.m. and October 30, 2012, from 

8 a.m. to 3 p.m. 

ADDRESSES: FDA is opening a docket for 

public comment on this meeting. The 

docket number is FDA–2012–N–0548. 

The docket will open for public 

comment on June 8, 2012. The docket 

will close on November 6, 2012. 

Interested persons may submit either 

electronic or written comments 

regarding this meeting. Submit 

electronic comments to http:// 

www.regulations.gov. Submit written 

comments to the Division of Dockets 

Management (HFA–305), Food and Drug 

Administration, 5630 Fishers Lane, rm. 

1061, Rockville, MD 20852. All 

comments received will be posted 

without change, including any personal 

information provided. It is only 

necessary to send one set of comments. 

Identify comments with the docket 

number found in brackets in the 

heading of this document. Received 

comments may be seen in the Division 

of Dockets Management between 9 a.m. 

and 4 p.m., Monday through Friday. 

Comments received on or before 

October 15, 2012, will be provided to 

the committee before the meeting. 

Location: FDA White Oak Campus, 

10903 New Hampshire Ave., Building 

31 Conference Center, the Great Room 

(rm. 1503), Silver Spring, MD 20993– 

0002. Information regarding special 

accommodations due to a disability, 

visitor parking, and transportation may 

be accessed at: http://www.fda.gov/ 

AdvisoryCommittees/default.htm; under 

the heading ‘‘Resources for You,’’ click 

on ‘‘Public Meetings at the FDA White 

Oak Campus.’’ Please note that visitors 

to the White Oak Campus must enter 

through Building 1. 

Contact Person: Kristina Toliver, 

Center for Drug Evaluation and 

Research, Food and Drug 

Administration, 10903 New Hampshire 

Ave., Bldg. 31, rm. 2417, Silver Spring, 

MD 20993–0002, 301–796–9001, FAX: 

301–847–8533, email: 

DSaRM@fda.hhs.gov, or FDA Advisory 

Committee Information Line, 1–800– 

741–8138 (301–443–0572 in the 

Washington, DC area), and follow the 

prompts to the desired center or product 

area. Please call the Information Line for 

up-to-date information on this meeting. 

A notice in the Federal Register about 

last minute modifications that impact a 

previously announced advisory 

committee meeting cannot always be 

published quickly enough to provide 

timely notice. Therefore, you should 

always check the Agency’s Web site and 

call the appropriate advisory committee 

hot line/phone line to learn about 

possible modifications before coming to 

the meeting. 

Agenda: On October 29 and 30, 2012, 

the committee will discuss the public 

health benefits and risks, including the 

potential for abuse, of drugs containing 

hydrocodone either combined with 

other analgesics or as an antitussive. 

The Department of Health and Human 

Services received a request from the 

Drug Enforcement Administration for a 

scientific and medical evaluation and 

scheduling recommendation for these 

products in response to continued 

reports of misuse, abuse, and addiction 

related to these products. 

FDA intends to make background 

material available to the public no later 

than 2 business days before the meeting. 

If FDA is unable to post the background 

material on its Web site prior to the 

meeting, the background material will 

be made publicly available at the 

mstockstill on DSK4VPTVN1PROD with NOTICES